OptimizeRx Corporation — Cash Flow (NASDAQ:OPRX) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities 6.31 M726.04 K10.65 M-7.24 M4.89 M 11.82 M Cash from investing activities 124.72 K-486 K-58.18 M-25.34 M450 K 258 K Cash from financing activities 1.9 M73.92 M-18.95 M28.22 M4.91 M 8.17 M Free cash flow 6.19 M240.04 K10.41 M-8.11 M4.44 M 11.57 M

Nouvelles

Intuit (INTU) Q2 Earnings and Revenues Top Estimates

Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength?

OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story

Jim Lang élu au conseil d’administration de Halozyme

New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More

OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript

Earnings call transcript: OptimizeRx’s Q3 2025 Earnings Beat Expectations

OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates

OPTIMIZERx earnings beat by $0.16, revenue topped estimates

Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday

L’objectif de prix d’OptimizeRX relevé à 23$ contre 20$ par Citizens

OptimizeRX price target raised to $23 from $20 at Citizens